Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,001.01
(
0.49%
)
News Focus
News Focus
Post# of 405181
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sox040713

Send PM Follow Ignore
Followers 55
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

sox040713

Re: sixmilliondollarbios post# 202161

Wednesday, 11/01/2017 9:46:49 PM

Wednesday, November 01, 2017 9:46:49 PM

Post# of 405181
K Phase 1 ended with the best scenario for the primary outcome. The trial concluded with the MAD (750 mg/m2) as the MTD. Eight more patients had to be recruited due to its safety profile.

Pharmacyclics' Imbruvica also took four years to complete Phase 1. Such is life in oncology trials. Not a red flag.

Kevetrin has essentially taken 5+ years to get move from IND to P2a.



FUD - Fear, uncertainty and doubt, is generally a strategic attempt to influence perception by disseminating negative and dubious or false information.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote